Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

NCT00126321 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myelocytic, Acute

Interventions

DRUG: cladribine

Sponsor

University Hospital, Bonn